• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

vaccines

vaccines
Posted inCOVID-19, Infections, New Drugs, Regulatory

Pfizer and Moderna Release Booster Vaccines to Protect Against Omicron

September 1, 2022September 20, 2022

Updated bivalent mRNA vaccines Comirnaty and Spikevax target Omicron subvariants BA.4 and BA.5.

moderna-vaccine
Posted inCOVID-19, Infections, Pharma & Biotech

Moderna Declared War on Pfizer

August 29, 2022September 8, 2022

Billions of dollars made from vaccines are at stake.

BCG Vaccination: Almost Absolute Protection Against COVID-19
Posted inClinical Trials, COVID-19, Infections

BCG Vaccination: Almost Absolute Protection Against COVID-19

August 22, 2022December 9, 2022

BCG is a universal vaccine that protects against SARS-CoV-2 coronavirus of any variant.

vaccine
Posted inCOVID-19, Infections, New Drugs, Regulatory

First Omicron Vaccine Appears

August 15, 2022September 8, 2022

Spikevax bivalent Original / Omicron (elasomeran + imelasomeran; mRNA-1273.214) by Moderna is the world’s first vaccine to protect against the Omicron variant of the SARS-CoV-2 coronavirus.

Covovax/Nuvaxovid: Nanoparticle Vaccine for COVID-19
Posted inCOVID-19, Infections, New Drugs, Regulatory

Covovax/Nuvaxovid: Nanoparticle Vaccine for COVID-19

July 14, 2022September 8, 2022

Covovax/Nuvaxovid by Novavax is a protein subunit vaccine from virus-like particles.

Covifenz: Medicago’s Plant-Derived COVID-19 Vaccine
Posted inCOVID-19, Infections, New Drugs, Regulatory

Covifenz: Medicago’s Plant-Derived COVID-19 Vaccine

June 5, 2022September 8, 2022

Innovative Medicago’s vaccine is made by molecular pharming technology.

Monkeypox 2022. Full Review
Posted inInfections, Research

Monkeypox 2022. Full Review

June 1, 2022September 12, 2022

Monkeypox as a new threat to humanity.

Posts navigation

1 2 3 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News